Identifying What to Measure in Acne Clinical Trials: First Steps towards Development of a Core Outcome Set.
作者信息
Layton Alison M, Eady E Anne, Thiboutot Diane M, Tan Jerry
机构信息
Department of Dermatology, Harrogate and District NHS Foundation Trust, Harrogate, UK.
Department of Dermatology, Harrogate and District NHS Foundation Trust, Harrogate, UK.
出版信息
J Invest Dermatol. 2017 Aug;137(8):1784-1786. doi: 10.1016/j.jid.2017.04.017. Epub 2017 Apr 27.
Abstract
摘要
相似文献
1
Identifying What to Measure in Acne Clinical Trials: First Steps towards Development of a Core Outcome Set.确定痤疮临床试验中需要测量的指标：核心结局集开发的第一步。
J Invest Dermatol. 2017 Aug;137(8):1784-1786. doi: 10.1016/j.jid.2017.04.017. Epub 2017 Apr 27.
2
3
Assessing effectiveness in acne clinical trials: steps towards a core outcome measure set.评估痤疮临床试验的疗效：迈向核心结局测量集的步骤。
Br J Dermatol. 2019 Oct;181(4):700-706. doi: 10.1111/bjd.18011. Epub 2019 May 29.
4
What dermatology still needs to create meaningful patient outcome measurements.
JAMA Dermatol. 2015 Apr;151(4):371-2. doi: 10.1001/jamadermatol.2014.3514.
5
67th annual meeting of the American Academy of Dermatology: San Francisco, California, USA, 6-10 March 2009.美国皮肤病学会第67届年会：2009年3月6日至10日，美国加利福尼亚州旧金山
Am J Clin Dermatol. 2009;10(3):205-10. doi: 10.2165/00128071-200910030-00009.
6
Using the Physician Global Assessment in a clinical setting to measure and track patient outcomes.在临床环境中使用医师总体评估来衡量和跟踪患者的结果。
JAMA Dermatol. 2015 Apr;151(4):375-81. doi: 10.1001/jamadermatol.2014.3513.
7
The changing face of challenges in the management of acne and rosacea.痤疮和玫瑰痤疮管理中不断变化的挑战面貌。
J Drugs Dermatol. 2014 Jun;13(6):649.
8
Acne vulgaris: pathogenesis, treatment, and needs assessment.寻常痤疮：发病机制、治疗和需求评估。
Dermatol Clin. 2012 Jan;30(1):99-106, viii-ix. doi: 10.1016/j.det.2011.09.001. Epub 2011 Oct 21.
9
[Clinical trials in dermatology. Evaluation of the tolerability and efficacy of a topical anti-acne].[皮肤病学临床试验。一种外用抗痤疮药物的耐受性和疗效评估]
Therapie. 1991 May-Jun;46(3):189-91.
10
The development and validation of an acne self-regulation inventory.痤疮自我调节量表的编制与验证
J Dermatol Sci. 2016 Nov;84(2):203-209. doi: 10.1016/j.jdermsci.2016.08.012. Epub 2016 Aug 18.
引用本文的文献
1
Measurement properties of the Comprehensive Quality-of-Life Measure for Acne (CompAQ): a cohort study at three international sites.痤疮综合生活质量量表（CompAQ）的测量属性：一项在三个国际地点开展的队列研究
Br J Dermatol. 2025 Jul 17;193(2):267-275. doi: 10.1093/bjd/ljaf127.
2
An Assessment of Current Clinician- and Patient-Reported Outcome Measures for Acne Scarring and Dyspigmentation: A Scoping Review.痤疮瘢痕和色素沉着的当前临床医生报告及患者报告结局指标评估：一项范围综述
J Invest Dermatol. 2025 Feb 27. doi: 10.1016/j.jid.2025.02.135.
3
Vaccines in Dermatology-Present and Future: A Review.皮肤病学中的疫苗：现状与未来综述
Vaccines (Basel). 2025 Jan 26;13(2):125. doi: 10.3390/vaccines13020125.
4
Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT.螺内酯治疗女性持续性面部痤疮的临床疗效和成本效益：SAFA 双盲 RCT。
Health Technol Assess. 2024 Sep;28(56):1-86. doi: 10.3310/MYJT6804.
5
Quality of patient-reported outcome measures for grading acne scars and dark marks: a COSMIN review.用于痤疮瘢痕和色素沉着评分的患者报告结局指标的质量：一项COSMIN综述
Arch Dermatol Res. 2024 Jan 10;316(2):70. doi: 10.1007/s00403-024-02815-6.
6
Systematic review of clinical practice guidelines for acne vulgaris published between January 2017 and July 2021.对2017年1月至2021年7月期间发表的寻常痤疮临床实践指南的系统评价。
Skin Health Dis. 2023 May 23;3(4):e240. doi: 10.1002/ski2.240. eCollection 2023 Aug.
7
Efficacy and safety of N-acetyl-GED-0507-34-LEVO gel in patients with moderate-to severe facial acne vulgaris: a phase IIb randomized double-blind, vehicle-controlled trial.N-乙酰-GED-0507-34-LEVO 凝胶治疗中重度寻常痤疮患者的疗效和安全性：一项 IIb 期随机双盲、赋形剂对照试验。
Br J Dermatol. 2022 Oct;187(4):507-514. doi: 10.1111/bjd.21663. Epub 2022 Jun 23.
8
International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual Meeting.国际皮肤病学结局测量指标（IDEOM）：2020 年年会报告。
Dermatology. 2022;238(3):430-437. doi: 10.1159/000518966. Epub 2021 Sep 17.
9
Patient-reported outcome measures for acne: a mixed-methods validation study (acne PROMs).痤疮患者报告结局测量工具：一项混合方法验证研究（痤疮 PROMs）。
BMJ Open. 2021 Mar 19;11(3):e034047. doi: 10.1136/bmjopen-2019-034047.
10
Identifying and appraising patient-reported outcome measures on treatment satisfaction in acne: a systematic review.识别和评价痤疮治疗满意度的患者报告结局测量指标：系统评价。
Br J Dermatol. 2021 Jul;185(1):36-51. doi: 10.1111/bjd.19675. Epub 2020 Dec 28.
本文引用的文献
1
The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology.特应性皮炎结局测量协调（HOME）路线图：制定皮肤病学核心结局测量集的方法学框架。
J Invest Dermatol. 2015 Jan;135(1):24-30. doi: 10.1038/jid.2014.320. Epub 2014 Sep 4.
2
Development of a new patient-reported outcome measure for facial acne: the Acne Symptom and Impact Scale (ASIS).一种用于面部痤疮的新的患者报告结局指标的开发：痤疮症状与影响量表（ASIS）。
J Drugs Dermatol. 2014 Mar;13(3):333-40.
3
Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.制定临床试验的核心结局测量集：OMERACT 筛选器 2.0。
J Clin Epidemiol. 2014 Jul;67(7):745-53. doi: 10.1016/j.jclinepi.2013.11.013. Epub 2014 Feb 28.
4
The Acne Quality of Life Index (Acne-QOLI): development and validation of a brief instrument.痤疮生活质量指数（Acne-QOLI）：一种简短工具的开发与验证
Am J Clin Dermatol. 2006;7(3):185-92. doi: 10.2165/00128071-200607030-00005.
5
Acne therapy: a methodologic review.
J Am Acad Dermatol. 2002 Aug;47(2):231-40. doi: 10.1067/mjd.2002.120912.
6
The development of an Acne Quality of Life scale: reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris.寻常痤疮生活质量量表的研制：轻至中度寻常痤疮患者中的信度、效度及与主观痤疮严重程度的关系
Acta Derm Venereol. 1998 Nov;78(6):451-6. doi: 10.1080/000155598442773.
7
Scarred for life?终身留下疤痕？
Dermatology. 1997;195 Suppl 1:15-21; discussion 38-40. doi: 10.1159/000246015.
8
Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials.评估面部痤疮患者与健康相关的生活质量：用于临床试验的自填式问卷的编制
Qual Life Res. 1996 Oct;5(5):481-90. doi: 10.1007/BF00540020.
9
How much disability is caused by acne?痤疮会导致多大程度的残疾？
Clin Exp Dermatol. 1989 May;14(3):194-8. doi: 10.1111/j.1365-2230.1989.tb00930.x.
Zotero 插件